Jarvis Securities plc
07 February 2008
Jarvis Securities plc
('Jarvis' or 'the Company')
Board Change/Director's Shareholding/Transaction in Own Shares
Jarvis Securities plc, the administration and outsourcing operation which
supplies retail execution only stock broking facilities as well as outsourced
investment services and Model B settlement, is pleased to announce the
appointment of Graeme McAusland B.Sc to the Board as a Non-Executive Director
with effect from 1 March 2008.
Graeme (aged 42) has held a number of senior positions and is on the Board of
The Children's Mutual where he holds the post of Chief Operating Officer
responsible for all financial and governance areas including compliance, risk
management and audit functions. He has implemented and managed a number of new
operating and business models to enhance and increase the scale of business,
having previously held the position of Financial Director and Appointed Actuary.
Prior to this, Graeme held various management roles including Head of Corporate
Development with Prudential plc and is a Fellow of the Faculty of Actuaries.
Graeme owns no shares or options in the Company at the present time.
The following information is disclosed pursuant to Rule 17, Schedule Two (g) of
the AIM Rules for Companies:
Current Appointments
Tunbridge Wells Insurance Services Limited
Tunbridge Wells Equitable Investments Company Limited
Tunbridge Wells Equitable Services Company
Graeme is also a member of the Management Board of the Tunbridge Wells Equitable
Friendly Society Limited
There is no further information to disclose.
Commenting on the appointment of Graeme to the Board, Andrew Grant, Chairman and
Chief Executive said:
'We are delighted that Graeme has agreed to join the Board of Jarvis. He will
bring his undoubted personal drive and expertise to enhance the Company's
strategy and operations'
John Mackay, who has been a non-Executive Director of the Company since 2004,
has in view of his other business commitments agreed to stand down as a
non-Executive Director effective from 29 February 2008. John has been very
helpful to us over the last 3 years and we would like to thank him for his
contribution to the Company's development and wish him well for the future.
On 5 February, prior to John's departure, he exercised Options previously
granted to him under the 2004 scheme pursuant to which he has acquired 50,000
Ordinary Shares at a price of 82.5p per share. Following this purchase, John is
beneficially interested in 50,000 Ordinary Shares representing approximately 0.4
per cent. of the Company's current issued share capital. The shares have been
satisfied from Treasury.
The Company announces that between 1 February 2008 and 6 February 2008 it
acquired 49,000 shares at an average price of 200.562p to be held in Treasury.
Following these transactions and the sale of shares to Mr Mackay, the Company
now holds nil Ordinary Shares in Treasury and has 10,800,000 Ordinary Shares in
issue.
For further information:
Jarvis Securities plc
Andrew Grant, Chairman & CEO Tel: 0870 224 1111
Daniel Stewart & Company plc
Lindsay Mair/Tessa Smith Tel: 020 7776 6550
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.